tiprankstipranks
PharmaCom BioVet Inc (PHMB)
OTHER OTC:PHMB
US Market
PHMB
PharmaCom BioVet
RESEARCH TOOLSreports
Want to see PHMB full AI Analyst Report?

PharmaCom BioVet (PHMB) Price & Analysis

14 Followers

PHMB Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

PHMB FAQ

What was PharmaCom BioVet Inc’s price range in the past 12 months?
Currently, no data Available
What is PharmaCom BioVet Inc’s market cap?
Currently, no data Available
When is PharmaCom BioVet Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PharmaCom BioVet Inc’s earnings last quarter?
Currently, no data Available
Is PharmaCom BioVet Inc overvalued?
According to Wall Street analysts PharmaCom BioVet Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does PharmaCom BioVet Inc pay dividends?
    PharmaCom BioVet Inc does not currently pay dividends.
    What is PharmaCom BioVet Inc’s EPS estimate?
    PharmaCom BioVet Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does PharmaCom BioVet Inc have?
    PharmaCom BioVet Inc has 10,784,783,000 shares outstanding.
      What happened to PharmaCom BioVet Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of PharmaCom BioVet Inc?
      Currently, no hedge funds are holding shares in PHMB
      What is the TipRanks Smart Score and how is it calculated?
      Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

        Company Description

        PharmaCom BioVet Inc

        PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.
        Similar Stocks
        Company
        Price & Change
        Follow
        Jaguar Animal Health
        MSP Recovery
        Universe Pharmaceuticals
        NewGenIvf Group
        Virax Biolabs Group Ltd. Class A
        Popular Stocks